Prevent Blindness America promotes new vision wellness program

Article

Prevent Blindness America recently launched the Healthy Eyes Vision Wellness Program to help businesses provide the tools employees need to protect their ocular health.

Key Points

Chicago-Prevent Blindness America recently launched the Healthy Eyes Vision Wellness Program to help businesses provide the tools employees need to protect their ocular health.

The program offers educational and promotional materials that deliver vision wellness information in the workplace. The materials, developed by ophthalmologists, optometrists, and research professionals, were designed to encourage employees to make vision care a health priority and to avoid morbidity from preventable ocular diseases.

Businesses that participate receive the Vision Wellness in the Workplace Promotion Guide, Prevent Blindness America's Healthy Vision Observance Calendar, monthly e-mails containing vision health and safety posters, fact sheets and eye health and safety news updates, the Common Eye Myths poster, the adult vision risk assessment for employees, and a sample Healthy Eyes Vision Wellness Guide.

To learn more about the Healthy Eyes Vision Wellness Program or to receive free information on eye safety in the workplace, call Prevent Blindness America at 800/331-2020 or go to http://www.preventblindness.org/.

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.